Filing Details
- Accession Number:
- 0001493152-20-005709
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-02 16:30:39
- Reporting Period:
- 2020-03-31
- Accepted Time:
- 2020-04-02 16:30:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1076682 | Polarityte Inc. | PTE | Biological Products, (No Disgnostic Substances) (2836) | 061529524 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744816 | Elliot Paul Mann | 123 Wright Brothers Drive Salt Lake City UT 84116 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-03-31 | 23,158 | $1.04 | 415,953 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12,2019, as amended November 19, 2019. The sale is intended to cover withholding taxes resulting from vesting ofrestricted stock units that were previously reported on Table I.
- The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from$1.00 to $1.145, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, orthe staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price that was included in the calculation of the weighted average price.